Atovaquone dosage and administration

Jump to navigation Jump to search
Atovaquone
MEPRON® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosage and Administration

Dosage

Prevention of PCP: Adults and Adolescents (13 to 16 Years)

The recommended oral dose is 1,500 mg (10 mL) once daily administered with a meal.

Treatment of Mild-to-Moderate PCP: Adults and Adolescents (13 to 16 Years)

The recommended oral dose is 750 mg (5 mL) administered with meals twice daily for 21 days (total daily dose 1,500 mg).

Note: Failure to administer MEPRON Suspension with meals may result in lower plasma atovaquone concentrations and may limit response to therapy (see CLINICAL PHARMACOLOGY and PRECAUTIONS).

Administration

Foil Pouch

Open pouch by removing tab at perforation and tear at notch. Take entire contents by mouth. Can be discharged into a dosing spoon or cup or directly into the mouth.

Bottle

SHAKE BOTTLE GENTLY BEFORE USING.[1]

References

  1. "MEPRON (ATOVAQUONE) SUSPENSION [GLAXOSMITHKLINE LLC]".

Adapted from the FDA Package Insert.